GSK Looking to Sell its Indian Consumer Health Unit for ~$4B

 GSK Looking to Sell its Indian Consumer Health Unit for ~$4B

GSK Looking to Sell its Indian Consumer Health Unit for ~$4B

Shots:
  •  GSK is holding 72.5% assets in India-Listed consumer healthcare unit, attracting Kellogg, Nestle, PepsiCo and Reckitt Benckiser in the sale
  •  GSK consumer-health unit also includes its 82% in Dhaka-listed GSK Bangladesh, having marketing rights to some consumer-health brands in other emerging markets including Malaysia
  • The Indian consumer-health unit, has multiple brands including popular milk brand Horlick, Boost, Viva, Maltova and OTC products Crocin, Sensodyne, Otrivin and Eno

Click here to read full press release/ article | Ref: Bloomberg | Image:  Pharma Pathway

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post